Costs for traditional meds static while specialty drug costs soar
Managed Care 21(6): 47
2012
ISSN/ISBN: 1062-3388 PMID: 22792564 Document Number: 658853
Document emailed within 1 workday
Related Documents
Jerome, D.; Laurent, C.; Catherine, B.; Didier, S.; Bertrand, C.; Muriel, R.; Joseph, M.; Olivier, Z.; Thiery, P.; Claude, C.J.an 2002: Costs of hospital management of hepatitis C virus cirrhosis in France Comparison between real costs and diagnosis related groups based costs Results of a multicentric study carried out on 267 consecutive patients in 1998 Hepatology 36(4 Part 2): 587AVon Ferber, L.; Köster, I.; Hauner, H. 1996: Direct costs of ambulatory treatment of diabetes mellitus. Comparison of observed costs with estimated costs of adherence to the treatment standard Medizinische Klinik 91(12): 802-808
Rabøl, R.; Kolbye, A.; Andersen, S.Ejdrup. 2003: Drug costs in departments of internal medicine. An analysis of costs for patients and departments Ugeskrift for Laeger 165(15): 1565-1568
Rudofsky, G.; van Laak, H.H. 1994: Treatment costs of peripheral arterial occlusive disease in Germany: a comparison of costs and efficacy Journal of Cardiovascular Pharmacology 23(Suppl): S22-S25
Rautenberg, R. 1983: Determining allowable reimbursable costs: PERT as a tool for hospital costs under Social Security Healthcare Financial Management: Journal of the Healthcare Financial Management Association 37(1): 48; 50
Peña, C.; Pujol, M.; Pallarés, R.; Corbella, X.; Vidal, T.; Tortras, N.; Ariza, J.; Gudiol, F. 1996: Estimation of costs attributable to nosocomial infection: prolongation of hospitalization and calculation of alternative costs Medicina Clinica 106(12): 441-444
Fogel, R.W.; Costa, D.L. 1997: A theory of technophysio evolution, with some implications for forecasting population, health care costs, and pension costs Demography 34(1): 49-66
Lubell, J. 2007: Revenue, costs rise 7% annually. Census data, AHRQ report sicker patients add to costs Modern Healthcare 37(50): 8-9
Prast, J.; Oppelt, P.; Shamiyeh, A.; Shebl, O.; Brandes, I.; Haas, D. 2013: Costs of endometriosis in Austria: a survey of direct and indirect costs Archives of Gynecology and Obstetrics 288(3): 569-576
Kolacz, J.W. 1975: Methods of computing costs of prophylaxis and therapy of parasitic diseases in domestic animals: costs and cost analysis Wiadomosci Parazytologiczne 21(2): 329-338
Simon, F.; Brun-Vezinet, F. 1993: HIV testing: reduce costs by all means, but not at all costs Lancet 342(8867): 379-380
Wright, S.; Henderson, C.; Thornicroft, G.; Sharac, J.; McCrone, P. 2015: Measuring the economic costs of discrimination experienced by people with mental health problems: development of the Costs of Discrimination Assessment (CODA) Social Psychiatry and Psychiatric Epidemiology 50(5): 787-795
Lee, J. 2014: Assessing drug value. Hospitals take steps to control drug costs and aid patients Modern Healthcare 44(48): 22; 24-25
Marum, M. 1997: General practice fundholding and health care costs. Fundholding has curbed increases in prescribing costs Bmj 315(7110): 748-749
Frost, F.J.; Craun, G.F.; Tollestrup, K.; Raucher, R.; Chwirka, J.; Stomp, J. 2001: Evaluation of costs and benefits of a lower arsenic MCL; unprecedented high costs for uncertain benefits New Mexico Geology 23(1): 13-15
Andersen, V. 1993: Drug costs Ugeskrift for Laeger 155(42): 3398-3399
Lexchin, J. 1989: Reducing drug costs New Zealand Medical Journal 102(872): 387
Bourla, A.; Johnson, S.R. 2015: Pharma 'could have done a better job' explaining drug costs Modern Healthcare 45(50): 30-31
Schwartz, H. 1981: Medical costs and the drug industry Medical Times 109(3): 21s-24s; 28s
Rico, M.J. 2000: Rising drug costs: the impact on dermatology Skin Therapy Letter 5(4): 1-2,5